ロード中...
Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer
BACKGROUND: Perturbation of the CDK4/6 pathway is frequently observed in advanced bladder cancer. We investigated the potential of targeting this pathway alone or in combination with chemotherapy or immunotherapy as a therapeutic approach for the treatment of bladder cancer METHODS: The genetic alte...
保存先:
| 出版年: | Cancer Immunol Immunother |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7572640/ https://ncbi.nlm.nih.gov/pubmed/32506263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-020-02609-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|